Skip to main content
Thor Medical ASA logo

Thor Medical ASA — Investor Relations & Filings

Ticker · NANOV ISIN · NO0010597883 LEI · 5967007LIEEXZXG6DK30 OL Manufacturing
Open in API
Filings indexed 106 across all filing types
Latest filing 2026-03-16 Director's Dealing
Country NO Norway
Listing OL NANOV

About Thor Medical ASA

https://www.thormedical.com/

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Recent filings

Filing Released Lang Actions
Thor Medical ASA - Primary insider notification - Redelivery and transfer of shares - Attachment: 20260313 - Thor Medical - Redelivery of shares - primary insider notification MAR.pdf
Director's Dealing Classification · 100% confidence The document is a standard notification of a transaction by a person discharging managerial responsibilities (PDMR) or a person closely associated with them, as required by the Market Abuse Regulation (MAR). It details the name of the entity, the issuer (Thor Medical ASA), the nature of the transaction (redelivery of lent shares), and the volume involved. This falls squarely under the definition of Director's Dealing (DIRS), which covers insider transactions and related party dealings in company shares.
2026-03-16 English
Thor Medical ASA - Primary insider notification - Redelivery and transfer of shares - Attachment: 20260316 - Thor Medical - Transfer of shares - primary insider notification B Good Industries AS.pdf
Director's Dealing Classification · 100% confidence The document contains multiple notifications of transactions by a person discharging managerial responsibilities (PDMR) and their closely associated entity, specifically citing the Market Abuse Regulation (MAR) Article 19. These are standard disclosures for insider trading or director dealings. Since the document details personal share transactions by company executives, it falls under the 'Director's Dealing' category.
2026-03-16 English
Thor Medical ASA - Primary insider notification - Redelivery and transfer of shares - Attachment: Download announcement as PDF.pdf
Director's Dealing Classification · 100% confidence The document is a notification regarding share transactions by primary insiders (CFO and COO) and the redelivery of shares under a share lending agreement. It explicitly references the Market Abuse Regulation (MAR) article 19, which governs disclosures of transactions by persons discharging managerial responsibilities. Since the document details specific share dealings by company insiders, it falls under the 'Director's Dealing' category.
2026-03-16 English
Thor Medical ASA - Primary insider notification - Redelivery and transfer of shares
Director's Dealing Classification · 100% confidence The document is a notification regarding share transactions by primary insiders (CFO and COO) and the redelivery of shares under a share lending agreement. It explicitly references the Market Abuse Regulation (MAR) article 19, which governs insider dealings. While it mentions attachments, the core content is the disclosure of insider trading activity, which falls under the 'Director's Dealing' category.
2026-03-16 English
Thor Medical ASA - New share capital registered - Attachment: Download announcement as PDF.pdf
Share Issue/Capital Change Classification · 100% confidence The document announces the registration of a new share capital following the exercise of share options. It explicitly mentions the new total share capital and the number of shares, which falls under the category of capital changes and share issuance. This aligns with the definition for 'Share Issue/Capital Change' (SHA).
2026-03-13 English
Thor Medical ASA - New share capital registered
Share Issue/Capital Change Classification · 100% confidence The document announces the registration of a new share capital following the exercise of share options. It explicitly mentions the new share capital amount, the number of shares, and the nominal value per share. This falls under the category of capital changes and share issuance announcements.
2026-03-13 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.